A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia

PHASE3CompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

April 30, 2012

Conditions
INSOMNIA
Interventions
DRUG

Eszopiclone

Eszopiclone - once a day (30 minutes before lying down to sleep for a period of 4 weeks of treatment)

DRUG

Zopiclone

Zopiclone - once a day (30 minutes before lying down to sleep for a period of 4 weeks of treatment)

Trial Locations (1)

Unknown

CRDB - Clinical Research & Development Brazil, São Paulo

Sponsors
All Listed Sponsors
lead

Eurofarma Laboratorios S.A.

INDUSTRY